Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: Evidence from marginal structural models used to adjust for time-dependent confounding

American Journal of Kidney Diseases

Volumn 63, Issue 6, 2014, Pages 979-987

  Fukagawa, Masafumi ^a   Kido, Ryo ^b,c   Komaba, Hirotaka ^a   Onishi, Yoshihiro ^b   Yamaguchi, Takuhiro ^b,d   Hasegawa, Takeshi ^b,e,f   Kurita, Noriaki ^b,c,f   Fukuma, Shingo ^b,c,f   Akizawa, Tadao ^e   Fukuhara, Shunichi ^b,c,f  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Institute for Health Outcomes and Process Evaluation Research   (Japan)

^c KYOTO UNIVERSITY FACULTY OF MEDICINE   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Calcium; clinical epidemiology; death; end stage renal disease; hemodialysis; hyperparathyroidism; hyperphosphatemia; mineral metabolism; parathyroid hormone (PTH)

Indexed keywords

CALCIUM; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D RECEPTOR;

ADULT; AGED; AORTA DISEASE; ARTICLE; CALCIUM BLOOD LEVEL; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; END STAGE RENAL DISEASE; EPIDEMIOLOGY; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; INCIDENCE; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MARGINAL STRUCTURAL MODEL; MATHEMATICAL MODEL; MINERAL METABOLISM; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PROSPECTIVE STUDY; SECONDARY HYPERPARATHYROIDISM; SUDDEN DEATH;

CALCIUM; CLINICAL EPIDEMIOLOGY; DEATH; END-STAGE RENAL DISEASE; HEMODIALYSIS; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; MINERAL METABOLISM; PARATHYROID HORMONE (PTH);

AGED; CALCIUM; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHORUS; RENAL DIALYSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 84901505238     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2013.08.011     Document Type: Article

References (42)

1. S. Moe, T. Drueke, and J. Cunningham et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Kidney Int 69 2006 1945 1953
2. G.A. Block, T.E. Hulbert-Shearon, and N.W. Levin et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study Am J Kidney Dis 31 1998 607 617
3. G.A. Block, P.S. Klassen, and J.M. Lazarus et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis J Am Soc Nephrol 5 2004 2208 2218
4. N. Kimata, J.M. Albert, and T. Akiba et al. Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan Dialysis Outcomes and Practice Patterns Study Hemodial Int 11 2007 340 348
5. F. Tentori, M.J. Blayney, and J.M. Albert et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS) Am J Kidney Dis 52 2008 519 530
6. E.W. Young, J.M. Albert, and S. Satayathum et al. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study Kidney Int 67 2005 1179 1187
7. S.K. Ganesh, A.G. Stack, and N.W. Levin et al. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients J Am Soc Nephrol 12 2001 2131 2138
8. M. Noordzij, J.C. Korevaar, and E.W. Boeschoten et al. The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients Am J Kidney Dis 46 2005 925 932
9. S. Nakai, T. Akiba, and J. Kazama et al. Effects of serum calcium, phosphorous, and intact parathyroid hormone levels on survival in chronic hemodialysis patients in Japan Ther Apher Dial 12 2008 49 54
10. R. Wald, M.J. Sarnak, and H. Tighiouart et al. Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study Am J Kidney Dis 52 2008 531 540
11. National Kidney Foundation K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease Am J Kidney Dis 42 4 suppl 3 2003 S1 S201
12. Kidney Disease Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) Kidney Int Suppl 113 2009 S1 S130
13. Guideline Working Group Japanese Society for Dialysis Therapy Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients Ther Apher Dial 12 2008 514 525
14. T. Akizawa, R. Kido, and M. Fukagawa et al. Decreases in PTH in Japanese hemodialysis patients with secondary hyperparathyroidism: associations with changing practice patterns Clin J Am Soc Nephrol 6 2011 2280 2288
15. M. Teng, M. Wolf, and M.N. Ofsthun et al. Activated injectable vitamin D and hemodialysis survival: a historical cohort study J Am Soc Nephrol 16 2005 1115 1125
16. G.A. Block, D. Zaun, and G. Smits et al. Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients Kidney Int 78 2010 578 589
17. T. Isakova, O.M. Gutierrez, and Y. Chang et al. Phosphorus binders and survival on hemodialysis J Am Soc Nephrol 20 2009 388 396
18. The EVOLVE investigators Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis N Engl J Med 367 2012 2482 2494
19. J.M. Robins Causal inference from complex longitudinal data M. Berkane, Latent Variable Modeling and Applications to Causality: Lecture Notes in Statistics 120 1997 Springer-Verlag New York, NY 69 117
20. B.D. Bradbury, M.A. Brookhart, and W.C. Winkelmayer et al. Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitations Am J Kidney Dis 54 2009 554 560
21. M.A. Hernan, B. Brumback, and J.M. Robins Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men Epidemiology 11 2000 561 570
22. S. Fukuhara, T. Akizawa, and M. Fukagawa et al. Mineral and Bone Disorders Outcomes Study for Japanese Chronic Kidney Disease Stage 5D Patients: rationale and study design Ther Apher Dial 15 2011 169 175
23. R.B. Payne, A.J. Little, and R.B. Williams et al. Interpretation of serum calcium in patients with abnormal serum proteins Br Med J 4 1973 643 646
24. W.E. Barlow, L. Ichikawa, and D. Rosner et al. Analysis of case-cohort designs J Clin Epidemiol 52 1999 1165 1172
25. S.R. Cole, M.G. Hudgens, and P.C. Tien et al. Marginal structural models for case-cohort study designs to estimate the association of antiretroviral therapy initiation with incident AIDS or death Am J Epidemiol 175 2012 381 390
26. G.A. Block, P. Raggi, and A. Bellasi et al. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients Kidney Int 71 2007 438 441
27. P.J. Roderick Assessing the impact of chronic kidney disease on individuals and populations: use of relative and absolute measures Nephrol Dial Transplant 27 suppl 3 2012 iii39 iii42
28. D.A. Goodkin, J.L. Bragg-Gresham, and K.G. Koenig et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS) J Am Soc Nephrol 14 2003 3270 3277
29. O.S. Indridason, and L.D. Quarles Comparison of treatments for mild secondary hyperparathyroidism in hemodialysis patients. Durham Renal Osteodystrophy Study Group Kidney Int 57 2000 282 292
30. S.C. Palmer, D.O. McGregor, and P. Macaskill et al. Meta-analysis: vitamin D compounds in chronic kidney disease Ann Intern Med 147 2007 840 853
31. W.G. Goodman, J. Goldin, and B.D. Kuizon et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis N Engl J Med 342 2000 1478 1483
32. M. Noordzij, E.M. Cranenburg, and L.F. Engelsman et al. Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients Nephrol Dial Transplant 26 2011 1662 1669
33. S.C. Palmer, A. Hayen, and P. Macaskill et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis JAMA 305 2011 1119 1127
34. K. Kalantar-Zadeh, N. Kuwae, and D.L. Regidor et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients Kidney Int 70 2006 771 780
35. W.G. Goodman The consequences of uncontrolled secondary hyperparathyroidism and its treatment in chronic kidney disease Semin Dial 17 2004 209 216
36. C. Gauci, O. Moranne, and B. Fouqueray et al. Pitfalls of measuring total blood calcium in patients with CKD J Am Soc Nephrol 19 2008 1592 1598
37. E. Slatopolsky, and J.A. Delmez Pathogenesis of secondary hyperparathyroidism Nephrol Dial Transplant 11 suppl 3 1996 130 135
38. M. Fukagawa, K. Yokoyama, and F. Koiwa et al. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder Ther Apher Dial 17 2013 247 288
39. D. Goldsmith, E. Ritz, and A. Covic Vascular calcification: a stiff challenge for the nephrologist: does preventing bone disease cause arterial disease? Kidney Int 66 2004 1315 1333
40. K. Lomashvili, P. Garg, and W.C. O'Neill Chemical and hormonal determinants of vascular calcification in vitro Kidney Int 69 2006 1464 1470
41. M. Tanaka, S. Yamazaki, and Y. Hayashino et al. Hypercalcaemia is associated with poor mental health in haemodialysis patients: results from Japan DOPPS Nephrol Dial Transplant 22 2007 1658 1664
42. A.A. Lopes, J.M. Albert, and E.W. Young et al. Screening for depression in hemodialysis patients: associations with diagnosis, treatment, and outcomes in the DOPPS Kidney Int 66 2004 2047 2053